Kiromic BioPharma Inc

NASDAQ:KRBP 3:59:27 PM EDT

4.11

+0.14 (+3.66%)

: $3.84 -0.27 (-6.57%)

Products

Kiromic Biopharma Announced On Dec 16 Submission Of Two Investigational New Drug Applications With U.S. FDA

Published: 12/17/2020 16:36 GMT

Kiromic BioPharma Inc (KRBP) - Kiromic Biopharma - Announced on Dec 16 Submission of Two Investigational New Drug Applications With U.S. FDA.
Kiromic Biopharma- Ind Application for Initiation of Phase 1 Clinical Trial of Iv Administered Allogenic Car-t for Eoc, Malignant Pleural Mesothelioma.
Kiromic Biopharma - Ind Application for Initiation of Phase 1 Clinical Trial of Ip Administered Allogenic Car-t for Eoc and Mpm.